Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
Saved in:
Main Authors: | Barry J. Byrne, Giancarlo Parenti, Benedikt Schoser, Ans T. van der Ploeg, Hung Do, Brian Fox, Mitchell Goldman, Franklin K. Johnson, Jia Kang, Nickita Mehta, John Mondick, M. Osman Sheikh, Sheela Sitaraman Das, Steven Tuske, Jon Brudvig, Jill M. Weimer, Tahseen Mozaffar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1540452/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liver transplantation in glycogen storage disease type III: A case‐series
by: Simon Gay, et al.
Published: (2025-01-01) -
Glycogen Storage Disease Type IX in a 6-year-old Male: A Case Report
by: Shahab Noorian, et al.
Published: (2024-10-01) -
Clinical manifestations in Egyptian Pompe disease patients: Molecular variability and enzyme replacement therapy (ERT) outcomes
by: Mohamed Abdelghafar Hussein, et al.
Published: (2025-01-01) -
Camptocormia as a feature of Mc Ardle's disease: A case report
by: Mathilde Nicolas, et al.
Published: (2025-03-01) -
Does p‐lactate increase in patients with GSD1 after ingesting a meal with common‐size sources of fructose and galactose? Observations from a prospective, non‐blinded, crossover pilot study
by: Camilla Diana B. Caroee, et al.
Published: (2025-01-01)